These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 28919793)

  • 41. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successes and failures of uterine leiomyoma drug discovery.
    Ali M; Chaudhry ZT; Al-Hendy A
    Expert Opin Drug Discov; 2018 Feb; 13(2):169-177. PubMed ID: 29254389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uterine artery embolization for symptomatic uterine fibroids.
    Gupta JK; Sinha A; Lumsden MA; Hickey M
    Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
    Pourcelot AG; Capmas P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):249-254. PubMed ID: 28403922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids.
    Garnock-Jones KP; Duggan ST
    Drugs; 2017 Oct; 77(15):1665-1675. PubMed ID: 28900897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on medical treatment of uterine fibroids.
    Faustino F; Martinho M; Reis J; Águas F
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():61-68. PubMed ID: 28732252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contemporary management of uterine fibroids: focus on emerging medical treatments.
    Singh SS; Belland L
    Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology].
    Brazert M; Korman MP; Pawelczyk LA
    Ginekol Pol; 2013 Sep; 84(9):794-800. PubMed ID: 24191519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.
    Talaulikar VS; Manyonda IT
    Adv Ther; 2012 Aug; 29(8):655-63. PubMed ID: 22903240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The economic impact of uterine fibroids in the United States: a summary of published estimates.
    Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
    J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
    Pérez-López FR
    Climacteric; 2015 Apr; 18(2):177-81. PubMed ID: 25390187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data.
    Neri M; Melis GB; Giancane E; Vallerino V; Pilloni M; Piras B; Loddo A; Paoletti AM; Mais V
    Int J Womens Health; 2019; 11():535-546. PubMed ID: 31695514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
    Lethaby A; Vollenhoven B; Sowter M
    BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uterine artery embolization for symptomatic uterine fibroids.
    Gupta JK; Sinha A; Lumsden MA; Hickey M
    Cochrane Database Syst Rev; 2012 May; (5):CD005073. PubMed ID: 22592701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.
    Trefoux Bourdet A; Luton D; Koskas M
    Int J Womens Health; 2015; 7():321-30. PubMed ID: 25848323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
    Szamatowicz M; Kotarski J
    Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.